Deutsche Bank Ag\ Brooklyn Immuno Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.48 - $2.03 $8,208 - $34,717	-17,102 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.76 - $4.84 $3,379 - $9,292	-1,920 Reduced 10.09%	17,102 $35,000
Q4 2021 Feb 11, 2022	BUY	$4.17 - $9.79 $4,019 - $9,437	964 Added 5.34%	19,022 $79,000
Q3 2021 Nov 04, 2021	BUY	$8.86 - $17.05 $25,959 - $49,956	2,930 Added 19.37%	18,058 $168,000
Q2 2021 Aug 11, 2021	BUY	$3.75 - $78.5 $56,730 - $1.19 Million	15,128 New	15,128 $273,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.